Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Dialysis

Normovolemia is a therapeutic target for hypertension

Nature Reviews Nephrology volume 5, pages 438–439 (2009)Cite this article

In patients with hypertension in hemodialysis, dry-weight reduction by additional ultrafiltration leads to decreases in systolic and diastolic blood pressure. Ultrafiltration combined with daily dietary salt restriction should, therefore, be recommended to these patients, even in the absence of clinical signs of volume overload.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hörl, M. P. & Hörl, W. H. Hemodialysis-associated hypertension: pathophysiology and therapy. Am. J. Kidney Dis. 39, 227–244 (2002).

    Article  Google Scholar 

  2. Wilson, I., Shah, T. & Nissenson, A. R. Role of sodium and volume in the pathogenesis of hypertension in hemodialysis. Semin. Dial. 17, 260–264 (2004).

    Article  Google Scholar 

  3. Lins, R. L. et al. Importance of volume factors in dialysis related hypertension. Clin. Nephrol. 48, 29–33 (1997).

    CAS  PubMed  Google Scholar 

  4. Agarwal, R., Alborzi, P., Satyan, A. & Light, R. P. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 53, 500–507 (2009).

    Article  CAS  Google Scholar 

  5. Charra, B. et al. Survival as an index of adequacy of dialysis. Kidney Int. 41, 1286–1291 (1992).

    Article  CAS  Google Scholar 

  6. Luik, A. J. et al. The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in hemodialysis patients: a prospective study. Am. J. Nephrol. 21, 471–478 (2001).

    Article  CAS  Google Scholar 

  7. Fagugli, R. M. et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol. Dial. Transplant. 18, 2332–2338 (2003).

    Article  Google Scholar 

  8. Fagugli, R. M. et al. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study. J. Nephrol. 19, 77–83 (2006).

    PubMed  Google Scholar 

  9. Davenport, A. Response to 'The long forgotten salt factor'. Kidney Int. 74, 964–965 (2008).

    Article  Google Scholar 

  10. Shaldon, S., Ozkahya, M., Ok, E., Basci, A. & Dorhout Mees, E. J. The long forgotten salt factor. Kidney Int. 74, 963–964 (2008).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renal Division, Department of Medicine, University of Cologne, Cologne, Germany

    Matthias P. Hörl

  2. Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria

    Walter H. Hörl

Authors
  1. Matthias P. Hörl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Walter H. Hörl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Walter H. Hörl.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hörl, M., Hörl, W. Normovolemia is a therapeutic target for hypertension. Nat Rev Nephrol 5, 438–439 (2009). https://doi.org/10.1038/nrneph.2009.93

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2009.93

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing